Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
Blue Earth Diagnostics, a leading provider of PET radiopharmaceuticals, is set to present findings on POSLUMA (flotufolastat F 18) injection at the ASTRO 2023 Annual Meeting. POSLUMA aids in PET scans to detect prostate-specific…
Continue Reading
Blood cancers are classified into three main types, each with several subtypes. The underlying cause is attributed to mutations in the DNA of blood cells that disrupt the normal control mechanisms that regulate cell…
Continue Reading
By Shania Kennedy
September 27, 2023 – Researchers at the University of Texas at Arlington (UTA) have been awarded a $450,000 grant from the National Institute of General Medical Sciences to develop a machine learning-based model…
Continue Reading
Skin diseases affect one-third of the global population, posing a major healthcare burden. Deep learning may optimise healthcare workflows through processing skin images via neural networks to make predictions. A focus of deep learning…
Continue Reading
AstraZeneca has tied up with Institut Kanser Negara, a centre of excellence for cancer care in Malaysia, to incorporate AI medical imaging into early lung cancer screening at government clinics and hospitals. WHY IT MATTERS
Lung…
What You Should Know:
– COTA, a real-world oncology data and analytics company announced the launch of Vista, a large-scale automated EHR dataset to accelerate cancer research and the deployment of trusted generative AI in cancer…
Continue Reading
Cancer detection technology startup Adela announced it secured $48 million in funding, bringing its total raise to $108 million. Labcorp joined the round as a new investor alongside existing investors OrbiMed, Decheng Capital, F-Prime Capital,…
Continue Reading
By Sara Heath
September 25, 2023 – Fewer than one in five oncology practices screen family caregivers for signs of emotional distress despite the significant burden these informal caregivers carry during a loved one’s cancer journey,…
Continue Reading
Led by 83North, This Round of Financing Brings Total Funding to Over $100 Million
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced it has closed a $55 million Series C financing round…
